Cargando…

Optimal Dose and Timing of Umbilical Stem Cells Treatment in Pulmonary Arterial Hypertensive Rats

PURPOSE: Pulmonary arterial hypertension (PAH) is a fatal disease which is characterized by an increase in pulmonary arterial pressure leading to increases in right ventricular afterload. Human umbilical cord blood derived-mesenchymal stem cells (hUCB-MSCs) administered via the jugular vein have bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hyeryon, Kim, Kwan Chang, Choi, Soo Jin, Hong, Young Mi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368143/ https://www.ncbi.nlm.nih.gov/pubmed/28332363 http://dx.doi.org/10.3349/ymj.2017.58.3.570

Ejemplares similares

The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats
por: Lee, Hyeryon, et al.
Publicado: (2015)

Change of voltage-gated potassium channel 1.7 expressions in monocrotaline-induced pulmonary arterial hypertension rat model
por: Lee, Hyeryon, et al.
Publicado: (2018)

Microarray analysis after umbilical cord blood derived mesenchymal stem cells injection in monocrotaline-induced pulmonary artery hypertension rats
por: Lee, Jae Chul, et al.
Publicado: (2014)

Changes in Caspase-3, B Cell Leukemia/Lymphoma-2, Interleukin-6, Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor Gene Expression after Human Umbilical Cord Blood Derived Mesenchymal Stem Cells Transfusion in Pulmonary Hypertension Rat Models
por: Kim, Kwan Chang, et al.
Publicado: (2016)

Effect of Ambrisentan Therapy on the Expression of Endothelin Receptor, Endothelial Nitric Oxide Synthase and NADPH Oxidase 4 in Monocrotaline-induced Pulmonary Arterial Hypertension Rat Model
por: Lee, Hyeryon, et al.
Publicado: (2019)

Changes of Bax, Bcl-2, CCR-2, MCP-1, and TGF-β1 genes in the left ventricle of spontaneously hypertensive rat after losartan treatment
por: Lee, Hyeryon, et al.
Publicado: (2019)

Therapeutic Effects of Umbilical Cord Blood Derived Mesenchymal Stem Cell-Conditioned Medium on Pulmonary Arterial Hypertension in Rats
por: Lee, Jae Chul, et al.
Publicado: (2015)

Notice of Retraction: Therapeutic Effects of Umbilical Cord Blood Derived Mesenchymal Stem Cell-Conditioned Medium on Pulmonary Arterial Hypertension in Rats
por: Lee, Jae Chul, et al.
Publicado: (2016)

Reduced immunoreactivities of B-type natriuretic peptide in pulmonary arterial hypertension rats after ranolazine treatment
por: Lee, Jae Chul, et al.
Publicado: (2016)

Apoptosis and remodeling in adriamycin-induced cardiomyopathy rat model
por: Hong, Young Mi, et al.
Publicado: (2017)

Losartan Reduces Remodeling and Apoptosis in an Adriamycin-Induced Cardiomyopathy Rat Model
por: Kim, Hyeon A, et al.
Publicado: (2023)

The effect of sildenafil on right ventricular remodeling in a rat model of monocrotaline-induced right ventricular failure
por: Bae, Hyun Kyung, et al.
Publicado: (2016)

Apoptosis and Inflammation Associated Gene Expressions in Monocrotaline-Induced Pulmonary Hypertensive Rats after Bosentan Treatment
por: Hong, Young Mi, et al.
Publicado: (2014)

Changes of blood pressure, abdominal visceral fat tissue and gene expressions in fetal programming induced rat model after amlodipine–losartan combination treatment
por: Lee, Ji Hyen, et al.
Publicado: (2016)

Changes of Pulmonary Pathology and Gene Expressions After Simvastatin Treatment in the Monocrotaline-Induced Pulmonary Hypertension Rat Model
por: Lee, Yun Hee, et al.
Publicado: (2011)

Mesenchymal stem cells suppress CaN/NFAT expression in the pulmonary arteries of rats with pulmonary hypertension
por: LIU, JUNFENG, et al.
Publicado: (2015)

Integrated care and optimal management of pulmonary arterial hypertension
por: Strange, Geoff, et al.
Publicado: (2009)

Gene Expressions of Nitric Oxide Synthase and Matrix Metalloproteinase-2 in Monocrotaline-Induced Pulmonary Hypertension in Rats After Bosentan Treatment
por: Koo, Hee Sun, et al.
Publicado: (2011)

Hypoxic pulmonary vasoconstriction and vascular contractility in monocrotaline-induced pulmonary arterial hypertensive rats
por: Kim, Hae Jin, et al.
Publicado: (2016)

Pulmonary arterial hypertension in pediatric patients undergoing high-dose carboplatin/thiotepa and stem cell transplant
por: Hackett, Gretchen, et al.
Publicado: (2021)

Changes of Gene Expression after Bone Marrow Cell Transfusion in Rats with Monocrotaline-Induced Pulmonary Hypertension
por: Kim, Kwan Chang, et al.
Publicado: (2012)

Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)
por: Ghofrani, Hossein A, et al.
Publicado: (2009)

Effect of Yiqi Buxue Decoction on Hemodynamic Changes of the Uterine Artery and Fetal Umbilical Artery and Pregnancy Outcomes in Pregnant Patients with Pulmonary Arterial Hypertension
por: Han, Rendong, et al.
Publicado: (2021)

Metallomics in pulmonary arterial hypertension patients
por: El‐Kersh, Karim, et al.
Publicado: (2023)

Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome
por: Callejo, María, et al.
Publicado: (2018)

Effect of Small Hairpin RNA Targeting Endothelin-Converting Enzyme-1 in Monocrotaline-Induced Pulmonary Hypertensive Rats
por: Son, Jae Sung, et al.
Publicado: (2012)

Optimization of culture conditions for rapid clinical-scale expansion of human umbilical cord blood-derived mesenchymal stem cells
por: Choi, Wankyu, et al.
Publicado: (2017)

Hemodynamic and Histopathologic Benefits of Early Treatment with Macitentan in a Rat Model of Pulmonary Arterial Hypertension
por: Kim, Kyung-Hee, et al.
Publicado: (2018)

Changes in the gut microbiome and metabolome in a rat model of pulmonary arterial hypertension
por: Hong, Wei, et al.
Publicado: (2021)

Total Occlusion of Right Main Pulmonary Artery in a Patient with Takayasu's Arteritis and Severe Pulmonary Hypertension
por: Choi, Hong-Mi, et al.
Publicado: (2012)

Catheterization of Pulmonary and Carotid Arteries for Concurrent Measurement of Mean Pulmonary and Systemic Arterial Pressure in Rat Models of Pulmonary Arterial Hypertension
por: Sarkar, Tanoy, et al.
Publicado: (2023)

Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension
por: Steiner, M Kathryn, et al.
Publicado: (2008)

Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension
por: Caccamo, Marco, et al.
Publicado: (2023)

Postpartum pulmonary circulation in pregnant rats with monocrotaline-induced pulmonary arterial hypertension
por: Jing, He, et al.
Publicado: (2020)

Comparison of reversal of rat pulmonary fibrosis of nintedanib, pirfenidone, and human umbilical mesenchymal stem cells from Wharton’s jelly
por: Chu, Kuo-An, et al.
Publicado: (2020)

An inhibitory effect of tumor necrosis factor-alpha antagonist to gene expression in monocrotaline-induced pulmonary hypertensive rats model
por: Kwon, Jung Hyun, et al.
Publicado: (2013)

HMGB1 Promotes the Development of Pulmonary Arterial Hypertension in Rats
por: Sadamura-Takenaka, Yukari, et al.
Publicado: (2014)

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Tong, Yi, et al.
Publicado: (2018)

Arctigenin prevents monocrotaline-induced pulmonary arterial hypertension in rats
por: Jiang, Wei-Long, et al.
Publicado: (2019)

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
por: Huang, Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_heu7bfavgocd3kvb5oc1htfes9